ATHA icon

Athira Pharma

98 hedge funds and large institutions have $68M invested in Athira Pharma in 2022 Q2 according to their latest regulatory filings, with 23 funds opening new positions, 37 increasing their positions, 22 reducing their positions, and 28 closing their positions.

New
Increased
Maintained
Reduced
Closed

more call options, than puts

Call options by funds: $ | Put options by funds: $

more repeat investments, than reductions

Existing positions increased: | Existing positions reduced:

less funds holding

Funds holding:

less ownership

Funds ownership:

18% less first-time investments, than exits

New positions opened: 23 | Existing positions closed: 28

81% less capital invested

Capital invested by funds: $354M → $68M (-$286M)

100% less funds holding in top 10

Funds holding in top 10: 10 (-1)

Holders
98
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$13.1M
Puts
$5.04M
Net Calls
Net Calls Change

Top Buyers

1 +$5.73M
2 +$4.18M
3 +$1.53M
4
BBA
Baker Bros. Advisors
New York
+$715K
5
Two Sigma Investments
Two Sigma Investments
New York
+$641K

Top Sellers

1 -$26.6M
2 -$25.7M
3 -$17.2M
4
VA
VR Adviser
New York
-$13.5M
5
Ameriprise
Ameriprise
Minnesota
-$7.89M
Name Holding Trade Value Shares
Change
Change in
Stake
101
102
103
104
105
106
107
108
109
110
111
112
113
114
115
116
117
118
119
120